go back

Ciltacabtagene Autoleucel (Carvykti) CAR-T Therapy

Arkansas rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated October 2026.

How much rates vary

Facilitymedian $707,946 · 10th to 90th $707,946 to $707,946Professionalmedian $707,946 · 10th to 90th $588,844 to $707,946
facility $707,946professional $707,946

Distribution of negotiated rates across all payers (price axis is log-scale). Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
None
Typical Low
$707,945.78
Median
$707,945.78
Typical High
$707,945.78
Aetna
Setting
Professional
Modifier
None
Typical Low
$588,843.66
Median
$707,945.78
Typical High
$707,945.78
United
Setting
Professional
Modifier
None
Typical Low
$588,843.66
Median
$676,082.98
Typical High
$676,082.98